15 December 2015 - PHARMAC is seeking feedback on a proposal involving budesonide with eformoterol inhalers (Symbicort Turbuhaler and Vannair), which are already listed in the Pharmaceutical Schedule in the Respiratory System and Allergies Therapeutic Group.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2015-12-15-budesonide-with-eformoterol/